Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4172
Full metadata record
DC FieldValueLanguage
dc.contributor.authorErturk, Emine Yurdakul-
dc.contributor.authorSayman, Ozden Aksu-
dc.contributor.authorYalcin, Onur-
dc.date.accessioned2024-03-15T08:08:45Z-
dc.date.available2024-03-15T08:08:45Z-
dc.date.issued2022-
dc.identifier.citationErturk, EY., Sayman, OA., Yalcin, O. (2022). COVID-19 in pediatric patients: Data from a training and research hospital COVID-19 in children. Ann. Clin. Anal. Med., 13(5), 568-572. https://doi.org/10.4328/ACAM.21038en_US
dc.identifier.issn2667-663X-
dc.identifier.urihttp://dx.doi.org/10.4328/ACAM.21038-
dc.identifier.urihttps://www.webofscience.com/wos/woscc/full-record/WOS:000795743000021-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4172-
dc.descriptionWoS Categories: Medicine, General & Internalen_US
dc.descriptionWeb of Science Index: Emerging Sources Citation Index (ESCI)en_US
dc.descriptionResearch Areas: General & Internal Medicineen_US
dc.description.abstractAim: Coronavirus Disease-19 (COVID-19), caused by severe acute syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide emergency. It is known that the course of the disease in pediatric COVID-19 is milder, with a better prognosis and lower rate of deaths. However, epidemiological and clinical data on children with COVID-19 are still scarce. The aim of this study is to describe the demographic, clinical and laboratory findings of children with COVID-19. Material and Methods: Medical records of patients aged under 18 years who had polyrnerase chain reaction (PCR) test for SARS-CoV-2 between March 15, 2020 and September 14, 2020 were examined retrospectively. Results: Of the 108 children infected with SARS-CoV-2, 52 (48.1%) were female, 56 (51.9%) were male, and the median age was 9 years (0-17 years). The most common presentation symptoms included fever (54.6%), fatigue or myalgia (32.4%). and cough (30.5%). Of all patients. 63.9% (n-53) had lymphopenia. Seventy (67.3%) cases with COVID-19 had a contact history. The median time from symptom onset to diagnosis was 1 (0-8) day. Posteroanterior chest X-ray was ordered in 80.5% (n-87) of the SARS-CoV-2 PCR positive patients, and only 5.7% (n-5) had findings in favor of infiltration. Chest computed tomography was ordered in four (3.7%) children, and one (25%) of them had findings consistent with COVID-19. Eight patients were hospitalized, one of whom was followed-up in the intensive care unit, and no patients died. Discussion: A better understanding of the clinical and laboratory characteristics of COVID-19 infection in children is very important in developing influential strategies to manage the disease.en_US
dc.language.isoengen_US
dc.publisherBAYRAKOL MEDICAL PUBLISHER-ANKARAen_US
dc.relation.isversionof10.4328/ACAM.21038en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChildren, COVID-19, SARS-CoV-2en_US
dc.titleCOVID-19 in pediatric patients: Data from a training and research hospital COVID-19 in childrenen_US
dc.typearticleen_US
dc.relation.journalANNALS OF CLINICAL AND ANALYTICAL MEDICINEen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.identifier.volume13en_US
dc.identifier.issue5en_US
dc.identifier.startpage568en_US
dc.identifier.endpage572en_US
Appears in Collections:Dahili Tıp Bilimleri

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.